Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2024

Aug 7, 2024

29841_dirs_2024-08-06_8752be16-2e65-4cd1-903d-381e75a49d53.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2024-08-02

Reporting Person: Walter Matthew R. (SVP, Chief HR Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-02 Ordinary Shares M 684 Acquired 25889 Direct
2024-08-02 Ordinary Shares F 210 $81.51 Disposed 25679 Direct
2024-08-02 Ordinary Shares F 231 $81.51 Disposed 25448 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-02 Performance Share Unit $ M 684 Disposed Ordinary Shares (684) Direct

Footnotes

F1: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents.

F2: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.

F3: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

F4: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F5: The performance share units vested on August 2, 2024.